Startups
Collaborations Pharmaceuticals, Inc.® is a privately owned company that performs research and development on innovative therapeutics for multiple rare and neglected infectious diseases.
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 24, 2026 | Collaborations Pharmaceuticals identifies a broad spectrum antiviral CPI-1058 against Ebola | Collaborations Pharmaceuticals, Inc. (CPI) recently identified CPI-1058 as a broad spectrum antiviral against Sudan and Bundibugyo strains of Ebola virus. RALEIGH, NC, UNITED STATES, September 24, 2026 /EINPresswire.com/ -- The latest outbr... |
| Sep 1, 2026 | Collaborations Pharmaceuticals and RTI International awarded an SBIR for long-acting treatment for HIV | Collaborations Pharmaceuticals logo RALEIGH, NC, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- Collaborations Pharmaceuticals, Inc. (CPI) is pleased to announce they were recently awarded a $306,870 Small Business Innovation Resear... |
| Jan 16, 2026 | Collaborations Pharmaceuticals, Inc. demonstrates a treatment for CLN1 Batten disease crosses the blood-brain-barrier | Collaborations Pharmaceuticals logo rhPPT1 is a recombinant protein used to treat an ultra-rare disease called Batten disease CLN1 for which there is currently no FDA approved treatment available. These findings suggest intravenous dosing o... |
| Oct 7, 2025 | Collaborations Pharmaceuticals, Inc., Partners with Bausch + Lomb to Publish Research on Advancing AI Drug Development | Mega eye logo Collaborations Pharmaceuticals logo RALEIGH, NC, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- Collaborations Pharmaceuticals, Inc. (CPI) has partnered with Bausch + Lomb to build and validate an array of artificial int... |
Reviews 0
FAQ about Collaborations
What has the press written about Collaborations?
Parsers VC has collected 5 articles mentioning Collaborations, among them “Collaborations Pharmaceuticals identifies a broad spectrum antiviral CPI-1058 against Ebola” (Sep 24, 2026) and “Collaborations Pharmaceuticals and RTI International awarded an SBIR for long-acting treatment for HIV” (Sep 1, 2026).
Is Collaborations still active?
Yes, Collaborations is active; its latest activity on Parsers VC dates from Sep 30, 2026.